ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

University of Chicago at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

University of Chicago takes part in 7 sessions at ESMO 2026 in Madrid. Its program centres on lung cancer treatment, with additional research in urinary, breast, and head and neck cancers. It explores antibody combinations for advanced lung cancer and biomarkers linked to treatment response.

OrganizationESMO 2026 Attendance
University & institute
Private research university in Chicago, Illinois, with a medical school and academic medical centre.
Abstract
Sat Oct 24
09:45–09:55
Invited Discussant LBA26, LBA96 and LBA15
Proffered paper 2: Breast cancer, early and advanced stage
Breast cancer
Satellite
Sat Oct 24
18:30–20:00
Pfizer - Breaking the Treatment Plateau in Advanced NSCLC: Antibody Therapy Redefined
with Hospital Clínic de Barcelona, University Hospital Cologne
Lung & thoracic cancers
Satellite
Sat Oct 24
18:30–18:35
Welcome & Introductions
Pfizer - Breaking the Treatment Plateau in Advanced NSCLC: Antibody Therapy Redefined
Lung & thoracic cancers
Satellite
Sat Oct 24
18:50–19:15
Bispecifics and ADCs on the Horizon: Evolving the Frontline Standards
Pfizer - Breaking the Treatment Plateau in Advanced NSCLC: Antibody Therapy Redefined
Lung & thoracic cancers
Satellite
Sat Oct 24
19:40–19:55
Looking Ahead: The Future Puzzle of aNSCLC Treatment
Pfizer - Breaking the Treatment Plateau in Advanced NSCLC: Antibody Therapy Redefined · with Hospital Clínic de Barcelona, University Hospital Cologne
Lung & thoracic cancers
Satellite
Sun Oct 25
19:10–19:40
Redefining 1L NSCLC: Precision Medicine Beyond Actionable Genomic Alterations
Daiichi Sankyo - Patient Identification in NSCLC: 10 From Actionable Genomic Alterations to Emerging ADC Opportunities
Lung & thoracic cancersBiomarkers & precision oncology
Chair
Mon Oct 26
10:15–11:45
Rapid oral: Non-metastatic NSCLC and other thoracic malignancies
with Medical University of Gdansk
Lung & thoracic cancers
Abstract
Mon Oct 26
11:17–11:29
Invited Discussant 4155RO, 4156RO and 4158RO
Rapid oral: Non-metastatic NSCLC and other thoracic malignancies
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Chicago

Tell us what you sell and we’ll find the people at University of Chicago most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction